FDA-Drug2026-07-29Class IICHEMICAL

Major Pharmaceuticals Levothyroxine Sodium 125 mcg tablets recalled for subpotency

LABEL MIX UPNationwide distributionDrugs

What this means

Major Pharmaceuticals is recalling specific lots of Levothyroxine Sodium 125 mcg tablets because they may contain less active ingredient than labeled. Levothyroxine is a thyroid replacement medication, and tablets that are weaker than expected could result in inadequate thyroid hormone levels.

  • Check if you have levothyroxine from lot N02266A, N02266B (bags) or N02266 (blisters), expiring 11/2026.
  • Contact your pharmacist or doctor if you have one of these lots.
  • Do not stop taking your levothyroxine without guidance; your doctor will advise on next steps.
The agency's original wording
Hazard

Subpotent Drug

Intended for
Adults
Illnesses reported
None reported
Sold states
Nationwide in the USA.
Affected count
N/A
Manufactured in
7000 Cardinal Pl, N/A, Dublin, OH, United States
Products
Levothyroxine Sodium Tablets, USP, 125 mcg (0.0125 mg), 10 Tablets (10 x 1) unit dose blisters per carton, Rx only, Packaged and Distributed by: MAJOR PHARMACEUTICALS, Indianapolis, IN 46268 USA. Distributed by Cardinal Health, Dublin, OH 43017. NDC Bag: 55154-3562-0; NDC Blister: 0904-6951-61

Official notice

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0710-2026

More Major Pharmaceuticals recalls

Want us to check the next one for you?

We read every CPSC, FDA, USDA, and NHTSA notice and email you a plain-English Sunday brief covering your household — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.

Free · One email a week · Unsubscribe anytime